0.61
-0.023(-3.65%)
Currency In USD
| Previous Close | 0.63 |
| Open | 0.65 |
| Day High | 0.63 |
| Day Low | 0.6 |
| 52-Week High | 2.74 |
| 52-Week Low | 0.36 |
| Volume | 456,928 |
| Average Volume | 15.24M |
| Market Cap | 72.84M |
| PE | -0.42 |
| EPS | -1.43 |
| Moving Average 50 Days | 0.79 |
| Moving Average 200 Days | 0.87 |
| Change | -0.02 |
If you invested $1000 in Invivyd, Inc. (IVVD) since IPO date, it would be worth $29.08 as of May 02, 2025 at a share price of $0.607. Whereas If you bought $1000 worth of Invivyd, Inc. (IVVD) shares 3 years ago, it would be worth $199.74 as of May 02, 2025 at a share price of $0.607.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank
GlobeNewswire Inc.
Apr 21, 2025 11:01 AM GMT
WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it has signed a $30 million term loan facilit
Invivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of Directors
GlobeNewswire Inc.
Mar 26, 2025 8:15 PM GMT
WALTHAM, Mass., March 26, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) is pleased to announce the appointment of Ajay Royan to its Board of Directors. Mr. Royan is a venture capitalist focused on transformational companies that have solved
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
GlobeNewswire Inc.
Mar 05, 2025 12:05 PM GMT
New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA™ (pemivibart) against LP.8.1 Centers for Disease Control reports LP.8.1, XEC and KP.3.1.1 together constitute the majority of current national SARS-CoV-2 va